Is Xenon Pharmaceuticals Inc. (XENE) a Buy, Sell, or Hold?
Xenon Pharmaceuticals Inc.
NASDAQ:XENE
$67.3 USD
-$0.42 (-0.62%)
- Volume
- 1.05M
- Average Volume
- 1.41M
- Market Capitalization
- $5.31B
- P/E Ratio
- -14.32
- Dividend Yield
- 0.00%
- Price Target
- $89.50
- Year High
- $72.66
- Year Low
- $30.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $27.79
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-24.8% DOWNSIDE
$89.50 Price Target
UPSIDE/DOWNSIDE HIGH
-32.7% DOWNSIDE
$100.00 Price Target High
UPSIDE/DOWNSIDE LOW
12.2% UPSIDE
$60.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Wells Fargo | Benjamin Burnett | $69 | $56.44 | 2026-05-10 10:17 AM | 22.3% |
| Needham | Serge Belanger | $78 | $56.545 | 2026-05-08 09:46 AM | 37.9% |
| Jefferies | Andrew Tsai | $100 | $62.76 | 2026-03-09 03:52 PM | 59.3% |
| Guggenheim | Yatin Suneja | $90 | $62.76 | 2026-03-09 02:47 PM | 43.4% |
| Stifel Nicolaus | Paul Matteis | $89 | $61.58 | 2026-03-09 09:30 AM | 44.5% |
| Jefferies | Andrew Tsai | $65 | $61.56 | 2026-03-09 09:18 AM | 5.6% |